Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Total monthly reach
Estimated from 2 chart positions in 2 markets.
By chart position
- 🇨🇦CA · Medicine#1475K to 30K
- 🇰🇷KR · Medicine#1821K to 10K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
3K to 20K🎙 ~2x weekly·34 episodes·Last published 1mo ago - Monthly Reach
Unique listeners across all episodes (30 days)
6K to 40K🇨🇦75%🇰🇷25% - Active Followers
Loyal subscribers who consistently listen
2.4K to 16K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
Recent episodes
Dr. David Ruslander | Lifelong Learning in Veterinary Oncology
Apr 12, 2026
Unknown duration
Dr. Karin Sorenmo | Mammary Tumors and Estrogen
Mar 15, 2026
Unknown duration
Dr. Guannan Wang | Precision Oncology Through Genomics
Jan 25, 2026
Unknown duration
Dr. Doug Thamm | Comparative Oncology Frontiers
Dec 21, 2025
Unknown duration
Dr. Joseph Impellizeri | Targeted Electrochemotherapy in Practice
Nov 2, 2025
Unknown duration
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Description | Length | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 4/12/26 | Dr. David Ruslander | Lifelong Learning in Veterinary Oncology | In this episode of the Veterinary Cancer Pioneers Podcast, host Dr. Rachel Venable welcomes Dr. David Ruslander, a dual-trained medical and radiation veterinary oncologist and past president of the Veterinary Cancer Society. Dr. Ruslander shares how he found his way into a specialty that barely existed at the time, including a formative chapter helping build veterinary oncology programs in Europe. The conversation covers how multimodality thinking shapes his approach to every case, how advances in radiation technology have expanded what is treatable, and why staying curious and current is non-negotiable for anyone who signed on for a career in veterinary medicine. 📝Transcripts are available at https://www.imprimedicine.com/podcast. To learn more about ImpriMed Personalized Prediction Profile, please visit https://www.imprimedicine.com/ppp Music Credit: Hazy by Beat Mekanik | — | ||||||
| 3/15/26 | Dr. Karin Sorenmo | Mammary Tumors and Estrogen | In this episode of the Veterinary Cancer Pioneers Podcast, host Dr. Rachel Venable welcomes Dr. Karin Sorenmo, Professor Emeritus of Oncology at the University of Pennsylvania School of Veterinary Medicine and co-founder of Lesley's Place. Dr. Sorenmo shares her journey from Norway to becoming a leading researcher in canine mammary tumors and discusses the complex role hormones play in tumor development and progression. The conversation explores how spaying patterns influence mammary cancer risk, why classification and pathology remain challenging worldwide, and what dogs can teach us about breast cancer through comparative oncology. Dr. Sorenmo also highlights the mission of Lesley's Place, where homeless dogs with mammary tumors receive surgical care, follow-up, and the opportunity to find loving homes while contributing valuable insights to cancer research. 📝Transcripts are available at https://www.imprimedicine.com/podcast. To learn more about ImpriMed Personalized Prediction Profile, please visit https://www.imprimedicine.com/ppp Music Credit: Hazy by Beat Mekanik | — | ||||||
| 1/25/26 | Dr. Guannan Wang | Precision Oncology Through Genomics | In this episode of the Veterinary Cancer Pioneers Podcast, host Dr. Rachel Venable welcomes Dr. Guannan Wang, founder of VetOmics, to discuss how comprehensive genomic profiling is advancing precision oncology for dogs. Dr. Wang shares her path from molecular biology research to veterinary cancer genomics, and explains why the field is shifting from "should we use genomics?" to "how do we do it well?" The conversation covers how genomic testing can guide therapy selection, support difficult diagnoses, and help identify true cancer drivers, while emphasizing the importance of real-world outcome follow-up and biomarker-guided combination strategies to improve patient care. 📝Transcripts are available at https://www.imprimedicine.com/podcast. To learn more about ImpriMed Personalized Prediction Profile, please visit https://www.imprimedicine.com/ppp Music Credit: Hazy by Beat Mekanik | — | ||||||
| 12/21/25 | Dr. Doug Thamm | Comparative Oncology Frontiers | In this episode of the Veterinary Cancer Pioneers Podcast, host Dr. Rachel Venable is joined by Dr. Doug Thamm, Stuart Presidential Chair in Oncology and Director of Clinical Research at the Colorado State University Flint Animal Cancer Center. Dr. Thamm discusses how naturally occurring cancers in dogs are advancing cancer drug development and informing treatment strategies in both veterinary and human medicine. He shares real-world examples of comparative oncology in action and the role clinical trials play in bringing new therapies to patients. The conversation also explores the challenges of oncology drug development, regulatory pathways, and emerging areas such as biologics, genomic sequencing, and AI-driven tools—offering a clear-eyed view of where veterinary oncology is headed. 📝Transcripts are available at https://www.imprimedicine.com/podcast. To learn more about ImpriMed Personalized Prediction Profile, please visit https://www.imprimedicine.com/ppp Music Credit: Hazy by Beat Mekanik | — | ||||||
| 11/2/25 | Dr. Joseph Impellizeri | Targeted Electrochemotherapy in Practice | In this episode of the Veterinary Cancer Pioneers Podcast, host Dr. Rachel Venable welcomes Dr. Joseph Impellizeri, a true trailblazer in targeted electrochemotherapy and gene electrotransfer immunotherapy. Dr. Impellizeri shares how electroporation-based treatments are transforming cancer care by allowing localized delivery of chemotherapy and immunotherapy with minimal side effects. He discusses how this technology has evolved from treating skin tumors to tackling complex cases like oral, nasal, and even bone cancers — and how it can complement traditional modalities such as surgery, chemotherapy, and radiation. The conversation also explores his groundbreaking work combining gene electrotransfer with PD-1 inhibitors, offering a glimpse into the future of veterinary oncology and more compassionate, targeted treatment options for patients. 📝Transcripts are available at https://www.imprimedicine.com/podcast. To learn more about ImpriMed Personalized Prediction Profile, please visit https://www.imprimedicine.com/ppp Music Credit: Hazy by Beat Mekanik | — | ||||||
| 10/6/25 | Dr. Chad Johannes | Navigating Career Transitions in Oncology | In this episode of the Veterinary Cancer Pioneers Podcast, host Dr. Rachel Venable welcomes Dr. Chad Johannes, Associate Professor and Executive Director of the Veterinary Teaching Hospital at Colorado State University and former medical director at Aratana Therapeutics, who also helped launch Palladia at Pfizer Animal Health (Now Zoetis). Dr. Johannes reflects on his path across private practice, industry, and academia — sharing practical lessons on burnout, career pivots, and the value of mentorship and flexibility in professional growth. The conversation explores how immunotherapy and AI are advancing precision oncology and how empowering general practitioners with options like CCNU, Laverdia, and Palladia can expand access to care. Tune in for a candid look at the economics and innovations shaping the next chapter of veterinary oncology. 📝Transcripts are available at https://www.imprimedicine.com/podcast. To learn more about ImpriMed Personalized Prediction Profile, please visit https://www.imprimedicine.com/ppp Music Credit: Hazy by Beat Mekanik | — | ||||||
| 9/7/25 | Dr. Jeannette Kelly | Inside Solo Oncology Practice | In this episode of the Veterinary Cancer Pioneers Podcast, host Dr. Rachel Venable welcomes Dr. Kelly to share insights from her career as a solo practitioner in veterinary oncology. Dr. Kelly reflects on the realities of running a private practice and the unique challenges and opportunities it presents. She highlights her open-minded approach to integrating a wide range of therapeutics and diagnostic tools, always with the goal of providing the best possible patient care. Throughout the conversation, Dr. Kelly also discusses how adaptability, clinical curiosity, and a patient-centered mindset have guided her work and shaped her contributions to the field. 📝Transcripts are available at https://www.imprimedicine.com/podcast. To learn more about ImpriMed Personalized Prediction Profile, please visit https://www.imprimedicine.com/ppp Music Credit: Hazy by Beat Mekanik | — | ||||||
| 8/2/25 | Dr. David Vail | Bridging Human & Veterinary Cancer Care | In this episode of the Veterinary Cancer Pioneers Podcast, host Dr. Rachel Venable welcomes Dr. David Vail, renowned veterinary oncologist, professor at the University of Wisconsin–Madison, and co-editor of the widely used Small Animal Clinical Oncology textbook. Dr. Vail reflects on the evolution of veterinary oncology over the past four decades, sharing pivotal developments such as the introduction of Tanovea and the wide-reaching impact of Cerenia. He explores the rise of comparative oncology and the increasingly bidirectional collaboration between veterinary and human medicine. The discussion highlights cutting-edge advances in immunotherapy and how combination therapies and naturally occurring canine cancer trials are shaping human clinical research. Tune in for a thoughtful look at the past, present, and future of oncology through the lens of a true pioneer. 📝Transcripts are available at https://www.imprimedicine.com/podcast. To learn more about ImpriMed Personalized Prediction Profile, please visit https://www.imprimedicine.com/ppp Music Credit: Hazy by Beat Mekanik | — | ||||||
| 5/25/25 | Dr. Steven Dow | Using Repurposed Drugs Against Cancer | In this episode of the Veterinary Cancer Pioneers Podcast, host Dr. Rachel Venable welcomes Dr. Steve Dow, professor of immunology at Colorado State University and Director of the Center for Immune and Regenerative Medicine. Dr. Dow shares insights from his groundbreaking work on myeloid-targeted immunotherapies and the innovative use of repurposed, FDA-approved drugs like losartan, palladia, and propranolol in treating canine cancers such as osteosarcoma and brain tumors. He also discusses the development of tumor vaccines, promising adjuvant trial results, and the critical role dogs play as translational models in advancing human cancer therapies. The episode highlights the future potential of bispecific antibodies and CAR-T cell therapies in both veterinary and human oncology. 📝Transcripts are available at https://www.imprimedicine.com/podcast. To learn more about ImpriMed Personalized Prediction Profile, please visit https://www.imprimedicine.com/ppp Music Credit: Hazy by Beat Mekanik | — | ||||||
| 5/4/25 | Dr. Steven Suter | Pioneering Bone Marrow Transplants in Dogs | In this episode of the Veterinary Cancer Pioneers Podcast, host Dr. Rachel Venable speaks with Dr. Steve Suter, a trailblazer in canine bone marrow transplantation, about his unexpected path into transplant research and the launch of the world's only academic bone marrow transplant program for dogs. Dr. Suter discusses the differences between autologous and allogeneic transplants, clinical protocols, and the emotional and logistical challenges behind this advanced treatment for canine lymphoma and leukemia. They delve into powerful case stories, donor matching hurdles, and the growing importance of early intervention and immunotherapy in veterinary oncology. Tune in to hear how Dr. Suter is reshaping cancer care for dogs—and why bone marrow transplants may offer new hope where traditional chemotherapy falls short. 📝Transcripts are available at https://www.imprimedicine.com/podcast. To learn more about ImpriMed Personalized Prediction Profile, please visit https://www.imprimedicine.com/personalized-prediction-profile Music Credit: Hazy by Beat Mekanik | — | ||||||
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 3/23/25 | Dr. Duncan Lascelles | Pain Management in Cancer Care | In this episode of the Veterinary Cancer Pioneers Podcast, host Dr. Rachel Venable welcomes Dr. Duncan Lascelles, a distinguished professor at North Carolina State University and a leading expert in veterinary pain management and surgery. Dr. Lascelles explores the complex relationship between pain and cancer in veterinary patients, highlighting how both cancer and its treatments can cause significant discomfort—and how pain itself may even influence cancer progression. Together, they dive into findings from clinical and laboratory studies and share best practices for pain assessment and management. Dr. Lascelles also emphasizes the importance of early intervention, client education, and the profound impact of effective pain control on patient outcomes and quality of life. Tune in to gain a deeper understanding of how thoughtful pain management can shape the future of veterinary oncology. 📝Transcripts are available at https://www.imprimedicine.com/podcast. To learn more about ImpriMed Personalized Prediction Profile, please visit https://www.imprimedicine.com/personalized-prediction-profile Music Credit: Hazy by Beat Mekanik | — | ||||||
| 3/5/25 | Dr. Mark Mamula | Advancing Canine Cancer Immunotherapy | In this episode of the Veterinary Cancer Pioneers Podcast, host Dr. Rachel Venable welcomes Dr. Mark Mamula, an immunologist and professor at Yale University School of Medicine, to discuss his groundbreaking work in canine cancer immunotherapy. Dr. Mamula shares how his background in autoimmune diseases led him to develop an experimental vaccine targeting EGFR and HER2 proteins in dogs with cancer. He explains the science behind this therapy, its clinical trial progress, and its potential to improve survival outcomes for cancers such as osteosarcoma and hemangiosarcoma. They also explore the challenges of bringing new therapies to veterinary medicine, the role of combination treatments, and the importance of accessible, cost-effective options for pet owners. Tune in for an insightful conversation on the evolving landscape of canine cancer treatment and the promising future of immunotherapy. 📝Transcripts are available at https://www.imprimedicine.com/podcast. To learn more about ImpriMed Personalized Prediction Profile, please visit https://www.imprimedicine.com/personalized-prediction-profile Music Credit: Hazy by Beat Mekanik | — | ||||||
| 1/26/25 | Dr. William Culp | Innovations in Veterinary Interventional Oncology | In this episode of the Veterinary Cancer Pioneers Podcast, host Dr. Rachel Venable welcomes Dr. William Culp, a professor of soft tissue surgery at UC Davis specializing in surgical oncology and interventional radiology. Dr. Culp shares his journey into veterinary medicine, the role of mentorship in his career, and his groundbreaking work in interventional oncology. They explore the evolving use of interventional radiology as a "fourth pillar" in oncology, discussing treatments like urethral stenting, prostate embolization, and liver tumor therapies. Tune in for an enlightening discussion on how these minimally invasive techniques are transforming options for veterinary cancer care. 📝Transcripts are available at https://www.imprimedicine.com/podcast. To learn more about ImpriMed Personalized Prediction Profile, please visit https://www.imprimedicine.com/personalized-prediction-profile Music Credit: Hazy by Beat Mekanik | — | ||||||
| 11/24/24 | Dr. Joelle Fenger | Bridging Science and Patient Care | In this episode of the Veterinary Cancer Pioneers Podcast, host Dr. Rachel Venable welcomes Dr. Joelle Fenger, a dedicated veterinary oncologist and clinician-scientist at Ethos Discovery. Dr. Fenger shares her unique insights on bridging the gap between research and patient care, discussing how her work at the intersection of science and practice shapes treatment strategies for companion animals with cancer. From her early training to recent studies, Dr. Fenger reflects on the challenges and rewards of her research, emphasizing the importance of evidence-based approaches in improving patient outcomes. Tune in to hear her journey and the impact of her work on the veterinary field. 📝Transcripts are available at https://www.imprimedicine.com/podcast. To learn more about ImpriMed Personalized Prediction Profile, please visit https://www.imprimedicine.com/personalized-prediction-profile Music Credit: Hazy by Beat Mekanik | — | ||||||
| 10/27/24 | Dr. Theresa Fossum | CBD Insights and Overcoming Challenges | In this episode of the Veterinary Cancer Pioneers Podcast, host Dr. Rachel Venable welcomes Dr. Theresa Fossum, a renowned veterinarian, surgeon, and CEO of Phoenix Animal Wellness and Dr. Fossum's Pet Care. Dr. Fossum shares her insights on the growing role of CBD products in veterinary care, emphasizing the importance of product quality and proper dosing for pets. She delves into the challenges of conducting clinical trials within corporate-owned hospital environments, highlighting the barriers to research and the critical need for larger multi-center studies. Dr. Fossum also explores how advancements in technology and AI are poised to transform veterinary diagnostics and streamline workflows, improving both care quality and efficiency. Tune in to gain a deeper understanding of the evolving landscape of veterinary medicine and the innovative solutions that are shaping its future. 📝Transcripts are available at https://www.imprimedicine.com/podcast. To learn more about ImpriMed Personalized Prediction Profile, please visit https://www.imprimedicine.com/personalized-prediction-profile Music Credit: Hazy by Beat Mekanik | — | ||||||
| 10/6/24 | Dr. Nicola Mason | Immunotherapy Innovations | In this episode of the Veterinary Cancer Pioneers Podcast, host Dr. Rachel Venable welcomes Dr. Mason, a leading figure in veterinary oncology and immunotherapy. Dr. Mason discusses her groundbreaking work at the University of Pennsylvania, where she leads the first canine cancer immunotherapy consortium backed by the Cancer Moonshot Initiative. With a background in immunology and extensive experience in developing innovative therapies for dogs with cancer, she highlights the importance of using canine models to better understand and accelerate human cancer treatments. The conversation delves into the complexities of tumor-immune system interactions, the evolution of immunotherapy, and exciting developments in off-the-shelf cellular therapies that could revolutionize treatment for both dogs and humans. Tune in to discover how veterinary science is paving the way for advancements in comparative oncology. PRE-medical Cancer Immunotherapy Network Canine Trials (PRECINCT): https://www.precinctnetwork.org/ Vetigenics: https://vetigenics.com/ 📝Transcripts are available at https://www.imprimedicine.com/podcast. To learn more about ImpriMed Personalized Prediction Profile, please visit https://www.imprimedicine.com/personalized-prediction-profile Music Credit: Hazy by Beat Mekanik | — | ||||||
| 9/15/24 | Dr. Chand Khanna | Comparative Oncology 2.0 | In this episode of the Veterinary Cancer Pioneers Podcast, Dr. Rachel Venable is joined by Dr. Chand Khanna, founder and board chair of Ethos Discovery, to explore the advancements in comparative oncology. Dr. Khanna delves into the concept of Comparative Oncology 2.0, discussing the increasing collaboration between human and animal health companies. They also examine the challenges of clinical trials, regulatory hurdles, and the future potential of comparative oncology in accelerating cancer drug development. Dr. Khanna highlights key examples of successful transactions between animal health and biotech companies. The conversation reveals how veterinary oncology can significantly contribute to human cancer treatment breakthroughs. Tune in for a deep dive into cutting-edge veterinary cancer research. Citation mentioned in the episode: Fenger JM, Eward W, Hendricks W, McNiel E, Johannes C, et al. (2020) Delivering Innovation to Oncology Drug Development Through Cancer Drug DISCO (Development Incentive Strategy using Comparative Oncology): Perspectives, Gaps and Solutions. Ann med clin Oncol 3: 120. DOI: 10.29011/AMCO-120.000120 (https://www.gavinpublishers.com/article/view/delivering-innovation-to-oncology-drug-development-through-cancer-drug-disco-development-incentive-strategy-using-comparative-oncology-perspectives-gaps-and-solutions) 📝Transcripts are available at https://www.imprimedicine.com/podcast. To learn more about ImpriMed Personalized Prediction Profile, please visit https://www.imprimedicine.com/personalized-prediction-profile Music Credit: Hazy by Beat Mekanik | — | ||||||
| 8/25/24 | Dr. Jolle Kirpensteijn | Adventures in Veterinary Oncology | In this episode of the Veterinary Cancer Pioneers Podcast, host Dr. Rachel Venable welcomes Dr. Jolle Kirpensteijn, Chief Veterinary Officer at Hill's Pet Nutrition, to share his inspiring journey from aspiring fighter pilot to becoming a leader in veterinary surgical oncology. Dr. Kirpensteijn discusses the pivotal moments that shaped his career, including his transition from general veterinary practice to specializing in small animal surgery and his subsequent move into academia and industry. He highlights the importance of agility, open-mindedness, and risk-taking in oncology, as well as the evolving landscape of veterinary surgery, particularly the exciting advancements in minimally invasive and robotic surgery. Dr. Kirpensteijn also reflects on the value of continuous learning and embracing change to maintain passion in one's career. Tune in to hear his motivational insights and gain a deeper understanding of the dynamic field of veterinary oncology. Check out Dr. Kirpensteijn's Podcasts: CatCafe Podcast (For Veterinary Professionals): https://catcafepodcast.net/ PurrPodcast (For Pet Parents): https://purrpodcast.net/ 📝Transcripts are available at https://www.imprimedicine.com/podcast. To learn more about ImpriMed Personalized Prediction Profile, please visit https://www.imprimedicine.com/personalized-prediction-profile Music Credit: Hazy by Beat Mekanik | — | ||||||
| 8/4/24 | Dr. Heather Wilson-Robles | Paths to Excellence | In this episode of the Veterinary Cancer Pioneers Podcast, Dr. Rachel Venable interviews Dr. Heather Wilson-Robles, Chief Medical Officer at Volition Veterinary and a seasoned veterinary oncologist with a rich history spanning academia and industry. Dr. Wilson-Robles shares insights on the crucial role mentorship has played throughout her career, starting from her early exposure to pediatric oncology, which led her to veterinary oncology. She discusses the significant impact that mentor-mentee relationships have had on her personal growth and professional development. The episode offers a deep dive into Dr. Wilson-Robles's contributions to the field and her ongoing efforts to advance veterinary oncology. 📝Transcripts are available at https://www.imprimedicine.com/podcast. To learn more about ImpriMed Personalized Prediction Profile, please visit https://www.imprimedicine.com/personalized-prediction-profile Music Credit: Hazy by Beat Mekanik | — | ||||||
| 7/14/24 | Dr. Nicole Ehrhart | Innovations in Aging Research | In this episode of the Veterinary Cancer Pioneers Podcast, Dr. Rachel Venable interviews Dr. Nicole Ehrhart, the Director of the Columbine Health Systems Center for Healthy Aging at Colorado State University. Dr. Ehrhart shares her inspiring journey from her early fascination with surgery to her pioneering work in comparative musculoskeletal oncology and regenerative medicine. She emphasizes the importance of veterinarians having a voice in broader medical and public health conversations, and discusses her innovative research into aging and cancer, highlighting the interconnectedness of these fields. This episode provides an insightful look into Dr. Ehrhart's impactful career and her vision for the future of veterinary and human medicine. 📝Transcripts are available at https://www.imprimedicine.com/podcast. To learn more about ImpriMed Personalized Prediction Profile, please visit https://www.imprimedicine.com/personalized-prediction-profile Music Credit: Hazy by Beat Mekanik | — | ||||||
| 6/23/24 | Dr. Julius Liptak | Inside Veterinary Surgical Oncology | In this episode of the Veterinary Cancer Pioneers Podcast, Dr. Rachel Venable interviews Dr. Julius Liptak, an internationally renowned surgical oncologist. Dr. Liptak shares his journey into veterinary surgical oncology, discusses the challenges of cancer surgeries, and emphasizes the importance of sentinel lymph node mapping. He also highlights the evolving landscape of veterinary oncology and the need for robust data to guide treatments. This episode offers valuable insights into the complexities and advancements in cancer treatment for pets. 📝Transcripts are available at https://www.imprimedicine.com/podcast. To learn more about ImpriMed Personalized Prediction Profile, please visit https://www.imprimedicine.com/personalized-prediction-profile Music Credit: Hazy by Beat Mekanik | — | ||||||
| 6/2/24 | Dr. Amy LeBlanc | Pets Paving Progress in Research | In this enlightening episode of the Veterinary Cancer Pioneers Podcast, host Dr. Rachel Venable speaks with Dr. Amy LeBlanc, a Senior Scientist and Director at the National Institute of Health's CCR Comparative Oncology Program. Dr. LeBlanc discusses the compelling integration of canine models into cancer research, emphasizing the translational benefits that dogs offer in understanding and treating human cancers. She highlights her team's work with naturally occurring cancers in pets, aiming to improve treatment options for both human and veterinary patients. The episode delves into the challenges and innovations in comparative oncology, showcasing how dogs, sharing our environments and cancers similar to humans, provide a unique bridge in cancer research that could lead to breakthrough therapies. 📝Transcripts are available at https://www.imprimedicine.com/podcast. To learn more about ImpriMed Personalized Prediction Profile, please visit https://www.imprimedicine.com/personalized-prediction-profile Music Credit: Hazy by Beat Mekanik | — | ||||||
| 5/12/24 | Dr. Chand Khanna | Incubating Scientific Innovation | In this insightful episode of the Veterinary Cancer Pioneers Podcast, Dr. Rachel Venable welcomes the esteemed Dr. Chand Khanna, founder and board chair of Ethos Discovery and a trailblazer in the field of veterinary and human oncology. With a remarkable career spanning academia, research, and clinical practice, Dr. Khanna shares his invaluable perspectives on the art of "communicative medicine" in veterinary oncology. Dr. Khanna provides an exciting update on the groundbreaking research being conducted at Ethos Discovery. He discusses the nationwide randomized prospective clinical trial for splenic hemangiosarcoma, which has already yielded valuable insights challenging conventional wisdom and offering new hope for curative outcomes. Join us to discover how these findings could revolutionize the treatment of canine cancer. 📝Transcripts are available at https://www.imprimedicine.com/podcast. To learn more about ImpriMed Personalized Prediction Profile, please visit https://www.imprimedicine.com/personalized-prediction-profile Music Credit: Hazy by Beat Mekanik | — | ||||||
| 4/21/24 | Dr. Mary Kay Klein | Trials and Triumphs in Oncology | In this compelling episode of the Veterinary Cancer Pioneers Podcast, host Dr. Rachel Venable engages in an inspiring conversation with Dr. Mary Kay Klein, a seasoned veterinary oncologist, educator, and practice owner from Southern Arizona. With decades of experience, Dr. Klein shares insights from her career, emphasizing the importance of clinical trials in advancing veterinary medicine and enhancing patient care. Her dedication to education and mentorship shines through as she discusses the impact of lifelong learning in the veterinary field. This episode not only highlights Dr. Klein's significant contributions to veterinary oncology but also explores her role in private practice ownership and her innovative approach to treatment and research. Join us for a journey into the heart of veterinary oncology with one of its most passionate advocates. 📝Transcripts are available at https://www.imprimedicine.com/podcast. To learn more about ImpriMed Personalized Prediction Profile, please visit https://www.imprimedicine.com/personalized-prediction-profile Music Credit: Hazy by Beat Mekanik | — | ||||||
| 3/31/24 | Dr. Philip Bergman | Pioneering Paths in Pet Cancer Care | In this episode of the Veterinary Cancer Pioneers Podcast, host Dr. Rachel Venable chats with Dr. Philip Bergman, known for his work on the Canine Melanoma Vaccine, Oncept®. Dr. Bergman shares his journey from considering a career in dairy practitioner to becoming a key player in the field of veterinary oncology. He talks about his experiences with human cancer research centers, the challenges he faced introducing new cancer treatments in veterinary medicine, and the importance of mentorship. Dr. Bergman also discusses the potential of treatments like checkpoint inhibitors. Get a glimpse into the evolving world of veterinary oncology, the collaboration between human and animal health research, and the practical challenges of making advanced treatments accessible. Note: This interview was recorded in November 2023. Since then, Dr. Bergman became the Director of Clinical Studies at Mars Veterinary Health, globally responsible for clinical studies. Transcripts are available at https://www.imprimedicine.com/podcast. To learn more about ImpriMed Personalized Prediction Profile, please visit https://www.imprimedicine.com/personalized-prediction-profile. Music Credit: Hazy by Beat Mekanik | — | ||||||
Showing 25 of 34
Sponsor Intelligence
Sign in to see which brands sponsor this podcast, their ad offers, and promo codes.
Chart Positions
2 placements across 2 markets.
Chart Positions
2 placements across 2 markets.